Skip to content

Welcome to Discover Pharma! Today is : November 19, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

drug discovery

  • Advanced Therapies,Drug Discovery & Development

    Enhanced Genomics appoints biotech veteran Dietrich Stephan as chair to drive next-gen target discovery

    Enhanced Genomics has appointed leading biotechnology entrepreneur Dietrich Stephan as [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Sofinnova Partners and NVIDIA join forces to boost European AI in life sciences

    Sofinnova Partners has announced a new collaboration with NVIDIA to [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development

    Revolutionizing omics and biopharma: Thermo Fisher Scientific’s latest instruments debut at ASMS 2025

    Thermo Fisher Scientific has unveiled a new suite of analytical [...]

    May 5, 2026
  • Uncategorised

    Selvita licenses Medicines Discovery Catapult’s target engagement technology

    Selvita has become the first contract research organisation (CRO) to [...]

    May 29, 2025
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Ochre Bio appoints pharma veteran Elaine Sullivan as senior independent director

    RNA therapeutics developer Ochre Bio has appointed Dr Elaine Sullivan [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development

    Domainex appoints Hayley French as CEO to drive next phase of growth

    Contract research organisation Domainex has named Hayley French as its [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development

    BioIVT and Handok Biotech form exclusive partnership to support research innovation in South Korea

    BioIVT, a global provider of biospecimen solutions for drug and [...]

    May 5, 2026
  • Advanced Therapies,Digital & Data,Drug Discovery & Development

    Alchemab strikes $415m licensing deal with Lilly for ALS candidate ATLX-1282

    UK-based Alchemab Therapeutics has signed a landmark licensing agreement with [...]

    May 5, 2026
  • Biotech & Pharma Business

    PhoreMost brings in biotech major players with $30B+ in deal history

    Company says appointments of Barbara Duncan and Stephen Dilly will [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development

    BioAscent taps new VP of Alliance Management to drive global growth

    BioAscent has appointed seasoned drug discovery executive Dr James Hitchin [...]

    May 5, 2026
Previous789Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Kamau gene editing restores adult haemoglobin in early sickle cell trial
    Categories: Advanced Therapies, Clinical & Regulatory, Research & Development, Therapeutic Areas
  • Commit Biologics nominates first complement engager drug candidate
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Research & Development, Therapeutic Areas
  • Caristo AI detects hidden cardiovascular risk in 19,110-patient study
    Categories: Digital & Data, Medical devices, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top